# Use of NPH Versus Basal Bolus Insulin for Steroid Induced Hyperglycemia

> **NCT03511521** · PHASE4 · TERMINATED · sponsor: **Northwestern University** · enrollment: 3 (actual)

## Conditions studied

- Hyperglycemia Steroid-induced
- Insulin Resistance, Diabetes

## Interventions

- **DRUG:** NPH Insulin
- **DRUG:** glargine
- **DRUG:** Insulin Aspart

## Key facts

- **NCT ID:** NCT03511521
- **Lead sponsor:** Northwestern University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2018-03-27
- **Primary completion:** 2019-08-15
- **Final completion:** 2019-08-15
- **Target enrollment:** 3 (ACTUAL)
- **Why stopped:** Unable to recruit sufficient number of patients
- **Last updated:** 2020-09-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03511521

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03511521, "Use of NPH Versus Basal Bolus Insulin for Steroid Induced Hyperglycemia". Retrieved via AI Analytics 2026-07-15 from https://api.ai-analytics.org/clinical/NCT03511521. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*